Point72 Asset Management L.P. 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:13 pm Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Point72 Asset Management L.P. | 56,207 0.200% | -2,045,830 (-97.33%) | Filing |
| 2022-10-14 9:10 pm Purchase | 2022-10-13 | 13G | Relmada Therapeutics, Inc. RLMD | Point72 Asset Management L.P. | 2,102,037 7.300% | 2,102,037 (New Position) | Filing |